Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?

被引：48
|
作者：
Guo, Ai [1 ]
Li, Kai [2 ]
Xiao, Qian [1 ]
机构：
[1] Chongqing Med Univ, Dept Geriatr, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing 400016, Peoples R China
来源：
EXPERIMENTAL GERONTOLOGY | 2020年 / 139卷
基金：
中国国家自然科学基金;
关键词：
Myokines; Skeletal muscle; Sarcopenic obesity; Sarcopenia; Biomarker; LEUKEMIA INHIBITORY FACTOR; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GROWTH-FACTOR; 21; BETA-AMINOISOBUTYRIC ACID; SERUM IRISIN LEVELS; FOLLISTATIN-LIKE; LEAN BODY-MASS; INSULIN-RESISTANCE; NEUROTROPHIC FACTOR;
D O I：
10.1016/j.exger.2020.111022
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Sarcopenic obesity (SO) is a condition characterized by the occurrence of both sarcopenia and obesity and imposes a heavy burden on the health of the elderly. Controversies and challenges regarding the definition, diagnosis and treatment of SO still remain because of its complex pathogenesis and limitations. Over the past few decades, numerous studies have revealed that myokines secreted from skeletal muscle play significant roles in the regulation of muscle mass and function as well as metabolic homeostasis. Abnormalities in myokines may trigger and promote the pathogenesis underlying age-related and metabolic diseases, including obesity, sarcopenia, type 2 diabetes (T2D), and SO. This review mainly focuses on the role of myokines as potential biomarkers for the early diagnosis and therapeutic targets in SO.
引用
收藏
页数：15
相关论文
共 50 条
  • [1] Sarcopenic obesity: emerging mechanisms and therapeutic potential
    Axelrod, Christopher L.
    Dantas, Wagner S.
    Kirwan, John P.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 146
  • [2] MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets
    Kimura, Muneyoshi
    Kothari, Sagar
    Gohir, Wajiha
    Camargo, Jose F.
    Husain, Shahid
    CLINICAL MICROBIOLOGY REVIEWS, 2023, 36 (04)
  • [3] The Potential of Ocular Exosomal Biomarkers as Therapeutic Targets, and as Diagnostic and Prognostic Indicators
    Klingeborn, M.
    Rickman, C. Bowes
    Stamer, W. D.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2017, 53 : S9 - S9
  • [4] Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets
    Lin, Jingmei
    Chuang, Chia-Chen
    Zuo, Li
    ONCOTARGET, 2017, 8 (10) : 17328 - 17346
  • [5] The role of circular RNAs in autoimmune diseases: Potential diagnostic biomarkers and therapeutic targets
    Li, Xin'ai
    Wang, Junhui
    Wang, Peng
    Qi, Shuo
    Amalraj, Jeremiah
    Zhou, Jingwei
    Ding, Zhiguo
    FASEB JOURNAL, 2025, 39 (02):
  • [6] Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension
    Li, Hongyan
    Liu, Yi
    Zhang, Hongli
    Shi, Xianbao
    Luo, Yue
    Fu, Gaoge
    Zhao, Churong
    Guo, Lixuan
    Li, Xin
    Shan, Lina
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [7] Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity
    Deemer, Sarah E.
    Roberts, Brandon M.
    Smith, Daniel L.
    Plaisance, Eric P.
    Philp, Andrew
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2024, 327 (01): : C140 - C150
  • [8] Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria
    Zhang, Yue
    Zhang, Hanyi
    Du, Shengyi
    Yan, Siyu
    Zeng, Jinrong
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (10) : 917 - 931
  • [9] Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors
    Alizadeh Pahlavani, Hamed
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Myokines as Possible Therapeutic Targets in Cancer Cachexia
    Manole, Emilia
    Ceafalan, Laura C.
    Popescu, Bogdan O.
    Dumitru, Carmen
    Bastian, Alexandra E.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
12345